comparemela.com
  1. Home
  2. Live Updates
  3. Ignal Meip Us55279b3015 - Breaking News

Latest Breaking News On - Ignal meip us55279b3015 - Page 1 : comparemela.com

MEI Pharma Announces Update of Ongoing Phase 1 Study Evaluating Oral CDK9 Inhibitor Voruciclib Alone and in Combination with Venetoclax in Patients with Acute Myeloid Leukemia or B-Cell Malignancies

‒ Voruciclib alone or in combination with venetoclax was generally well tolerated with no significant myelosuppression ‒ – Encouraging preliminary efficacy signal demonstrated. | May 23, 2023

Richard ghaliePharma incSafety review committeeNational cancer instituteDan goldPreliminary safetyAcute myeloid leukemiaMostb cellPrivate securities litigation reform actMei pharmaNc stock exchangePress releaseIgnal meip us55279b3015

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.